Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Effects of Compression in Mixed Ulcers.

Condition:   Ulcer
Intervention:   Other: No intervention
Sponsor:   Groupe Hospitalier Paris Saint Joseph
Completed - verified July 2016

Ischemic Pain Control With Analgesic Methods Clinical Trial

Condition:   Arterial Occlusive Diseases
Interventions:   Procedure: Continuous peripheral sciatic nerve block;   Drug: Fentanyl;   Drug: Ropivacaine;   Device: Perineural catheter
Sponsor:   University of Sao Paulo General Hospital
Not yet recruiting - verified July 2016

A Clinical Study Using Adipose-derived Stem Cells for Diabetic Foot

Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: Adipose-derived stem cell;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified July 2016

Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications

Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: Umbilical Cord Mesenchymal Stem Cells;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified July 2016

Ramipril Treatment of Claudication

Condition:   Peripheral Arterial Disease
Intervention:   Drug: Ramipril
Sponsor:   University of Nebraska
Recruiting - verified July 2016

Claudication Evaluation During Rowing ExerciseS

Condition:   Peripheral Artery Disease
Intervention:  
Sponsor:   University Hospital, Angers
Not yet recruiting - verified July 2016

Tissue Lesions in Exercise Related Ischemia

Conditions:   Ischemia;   Peripheral Artery Disease
Intervention:   Other: Muscle Biopsy
Sponsor:   University Hospital, Angers
Not yet recruiting - verified July 2016

A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications

Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: mesenchymal stem cells;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified July 2016

A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation

Conditions:   Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease;   Vascular Disease;   Arterial Occlusive Disease;   Arteriosclerosis;   Atherosclerosis;   Cardiovascular Disease;   Pathologic Processes;   Orthopedic Procedures;   Amputation
Intervention:   Biological: Allogeneic bone marrow derived mesenchymal stem cells
Sponsor:   Indiana University
Recruiting - verified July 2016

BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI

Conditions:   Peripheral Arterial Disease;   Critical Limb Ischemia
Intervention:   Other: BOLD-MRI
Sponsor:   Biomet, Inc.
Recruiting - verified May 2016

Ticagrelor and Peripheral Arterial Disease

Condition:   Peripheral Arterial Disease
Interventions:   Procedure: Percutaneous Peripheral Intervention;   Device: Optical Coherence Tomography;   Other: Ankle Brachial Index;   Other: Six minute walk distance assessment;   Drug: Aspirin;   Drug: Aspirin + Ticagrelor
Sponsors:   Arkansas Heart Hospital;   The University of Texas Health Science Center at San Antonio;   University of Alabama at Birmingham
Recruiting - verified July 2016

Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)

Condition:   Systemic Lupus Erthematosus
Interventions:   Radiation: PET/CT;   Drug: Pioglitazone;   Procedure: Vascular function studies
Sponsor:   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2016

Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease

Conditions:   Peripheral Arterial Disease;   Diabetic Foot
Interventions:   Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
Sponsor:   Celgene Corporation
Recruiting - verified July 2016

Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity

Condition:   Peripheral Artery Disease
Intervention:   Device: Lutonix Drug Coated Balloon Catheter
Sponsor:   C. R. Bard
Terminated - verified July 2016

Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU

Conditions:   Peripheral Arterial Disease;   Diabetic Foot
Interventions:   Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Biological: 100 x 10^6 cells
Sponsor:   Celgene Corporation
Active, not recruiting - verified July 2016

EverFlex Post Approval Study

Conditions:   Peripheral Arterial Disease;   Lower Extremity Arterial Disease
Intervention:   Device: EverFlex™ Self-Expanding Peripheral Stent System
Sponsor:   Medtronic Endovascular
Recruiting - verified July 2016

PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease

Conditions:   Chronic Kidney Disease;   Diabetes
Intervention:   Drug: Darbepoetin alfa
Sponsors:   Translational Research Informatics Center, Kobe, Hyogo, Japan;   Showa University School of Medicine
Active, not recruiting - verified July 2016